Sung-Gil Chi
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Cell death mechanisms and regulation
- RNA Research and Splicing
Papers in
-
- TGF-β signaling in diseases 5
- Cell death mechanisms and regulation 4
-
- NF-κB Signaling Pathways 6
- Co-authors
- Byung-Kyu Ryu (12 shared papers)Jong Seung Kim (7 shared papers)Min Goo Lee (7 shared papers)Hyo-Jong Kim (4 shared papers)Min-Goo Lee (7 shared papers)Lloyd C. Trotman (1 shared paper)Nikola P. Pavletich (1 shared paper)Xinjiang Wang (1 shared paper)
- Journals
- Oncogene (3 papers)Canadian Journal of Physiology and Pharmacology (3 papers)International Journal of Molecular Sciences (2 papers)Biochemical and Biophysical Research Communications (2 papers)Cancer Research (2 papers)
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
Sung-Gil Chi
69 papers receiving 2.9k citations
Sung-Gil Chi's Hit Papers
Peers
Comparison fields: 5 of 114
- Cancer Research 490
- Molecular Biology 1.8k
- Oncology 486
- Cell Biology 240
- Immunology 276
Countries citing papers authored by Sung-Gil Chi
This map shows the geographic impact of Sung-Gil Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung-Gil Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung-Gil Chi more than expected).
Fields of papers citing papers by Sung-Gil Chi
This network shows the impact of papers produced by Sung-Gil Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung-Gil Chi. The network helps show where Sung-Gil Chi may publish in the future.
Co-authors
The 25 scholars most cited alongside Sung-Gil Chi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ubiquitination Regulates PTEN Nuclear Import and Tumor Suppression Hit paper breakdown → | 2007 | 595 |
| 2 | 2003 | 158 | |
| 3 | 2019 | 124 | |
| 4 | 2020 | 119 | |
| 5 | 2012 | 106 | |
| 6 | 2001 | 106 | |
| 7 | 2022 | 105 | |
| 8 | 2005 | 99 | |
| 9 | 2019 | 98 | |
| 10 | 2011 | 92 | |
| 11 | 2016 | 86 | |
| 12 | 2012 | 82 | |
| 13 | 2010 | 60 | |
| 14 | 1997 | 57 | |
| 15 | 2014 | 56 | |
| 16 | 2011 | 47 | |
| 17 | 2012 | 47 | |
| 18 | 2018 | 47 | |
| 19 | 2012 | 44 | |
| 20 | 2020 | 44 |
About Sung-Gil Chi
Sung-Gil Chi is a scholar working on Molecular Biology, Cancer Research, Oncology, Cell Biology and Immunology, having authored 72 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (7 papers), Caveolin-1 and cellular processes (7 papers), NF-κB Signaling Pathways (6 papers), Nanoplatforms for cancer theranostics (6 papers), TGF-β signaling in diseases (5 papers), interferon and immune responses (4 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Cell death mechanisms and regulation (4 papers). The work is most often cited by research in Cancer Research (490 citations), Molecular Biology (1.8k citations), Oncology (486 citations), Cell Biology (240 citations) and Immunology (276 citations). Sung-Gil Chi has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Byung-Kyu Ryu, Jong Seung Kim, Min Goo Lee, Hyo-Jong Kim, Min-Goo Lee, Lloyd C. Trotman, Nikola P. Pavletich, Xinjiang Wang, Julie Teruya‐Feldstein and Carlos Cordon‐Cardo. Their work appears in journals such as Oncogene, Canadian Journal of Physiology and Pharmacology, International Journal of Molecular Sciences, Biochemical and Biophysical Research Communications and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.